![Darren Shafren](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Darren Shafren
Fondatore presso ImmVirX Pty Ltd.
Profilo
Darren Shafren is the founder of ImmVirX Pty Ltd.
He is currently an Associate Professor at The University of Newcastle.
Previously, he served as the Chief Scientific Officer at Viralytics Pty Ltd.
from 2009 to 2019.
Posizioni attive di Darren Shafren
Società | Posizione | Inizio |
---|---|---|
The University of Newcastle | Corporate Officer/Principal | - |
ImmVirX Pty Ltd.
![]() ImmVirX Pty Ltd. Miscellaneous Commercial ServicesCommercial Services ImmVirX Pty Ltd. develops oncotic viral immunotherapy. The Australian company was founded in 2019 by Malcolm L. McColl and Darren Shafren. Malcolm L. McColl has been the CEO since 2019. | Fondatore | - |
Precedenti posizioni note di Darren Shafren
Società | Posizione | Fine |
---|---|---|
VIRALYTICS LTD. | Direttore della Ricerca - Azioni | 25/10/2009 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Viralytics Pty Ltd.
![]() Viralytics Pty Ltd. BiotechnologyHealth Technology Viralytics Pty Ltd. engages in the development and commercialization of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its product, CAVATAK, is a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21. The company was founded in 1984 and is headquartered in Sydney, Australia. | Health Technology |
ImmVirX Pty Ltd.
![]() ImmVirX Pty Ltd. Miscellaneous Commercial ServicesCommercial Services ImmVirX Pty Ltd. develops oncotic viral immunotherapy. The Australian company was founded in 2019 by Malcolm L. McColl and Darren Shafren. Malcolm L. McColl has been the CEO since 2019. | Commercial Services |
- Borsa valori
- Insiders
- Darren Shafren